Aldo Renault

518 total citations
9 papers, 156 citations indexed

About

Aldo Renault is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Aldo Renault has authored 9 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Genetics. Recurrent topics in Aldo Renault's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers) and Advanced Breast Cancer Therapies (2 papers). Aldo Renault is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers) and Advanced Breast Cancer Therapies (2 papers). Aldo Renault collaborates with scholars based in France, United States and Belgium. Aldo Renault's co-authors include Florian Guisier, C. Chouaïd, J.B. Auliac, Franck Morin, Clarisse Audigier-Valette, Marie Wislez, Pierre-Jean Souquet, P. Merle, Denis Moro‐Sibilot and M. Marcq and has published in prestigious journals such as Journal of Clinical Oncology, Cancers and Journal of Thoracic Oncology.

In The Last Decade

Aldo Renault

8 papers receiving 153 citations

Peers

Aldo Renault

PRM

ONCOL

CR

MB

EPIDE

Aurelia Alexandru Romania

Sara Manglaviti Italy

Rubén Dario Kowalyszyn United States

Patricia Iranzo Spain

Julia Dudnik Israel

Christian Boch Germany

Deepti Venkatraman United States

Marie Naigeon France

C. Clary France

Aiping Zhou China

Aurelia Alexandru Romania

Aldo Renault

111 ×0.9

PRM

111 ×1.1

ONCOL

24 ×0.8

CR

14 ×0.7

MB

12 ×0.7

EPIDE

Citations per year, relative to Aldo Renault Aldo Renault (= 1×) peers Aurelia Alexandru

Countries citing papers authored by Aldo Renault

Since Specialization

Citations

This map shows the geographic impact of Aldo Renault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Renault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Renault more than expected).

Fields of papers citing papers by Aldo Renault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Renault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Renault. The network helps show where Aldo Renault may publish in the future.

Co-authorship network of co-authors of Aldo Renault

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Renault. A scholar is included among the top collaborators of Aldo Renault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Renault. Aldo Renault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Assié, Jean‐Baptiste, Emmanuel Grolleau, Anthony Canellas, et al.. (2022). Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study. Cancers. 14(6). 1498–1498. 11 indexed citations

2.

Toffart, Anne‐Claire, et al.. (2021). Proposal for a general framework for the administration of anticancer immunotherapy in a hospital-at-home care. Bulletin du Cancer. 109(1). 98–105.

3.

Herbreteau, Guillaume, Alexandra Langlais, Laurent Greillier, et al.. (2020). Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab. Journal of Clinical Medicine. 9(12). 3861–3861. 31 indexed citations

4.

Besse, Benjamin, Fabrice Barlési, Ingel Demedts, et al.. (2018). 135O A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer. Journal of Thoracic Oncology. 13(4). S76–S76. 1 indexed citations

5.

Auliac, J.B., M. Pérol, David Planchard, et al.. (2018). P1.13-09 Efficacy and Tolerance of Osimertinib in Real Word Setting: Results of the French Early Access Program (EXPLORE T790M GFPC Study). Journal of Thoracic Oncology. 13(10). S585–S585. 1 indexed citations

6.

Auliac, J.B., M. Pérol, David Planchard, et al.. (2018). Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation. Lung Cancer. 127. 96–102. 31 indexed citations

7.

Auliac, J.B., G François, Henri Janicot, et al.. (2018). Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors. Targeted Oncology. 13(4). 501–507. 35 indexed citations

8.

Wislez, Marie, Fabrice Barlési, Benjamin Besse, et al.. (2014). Customized Adjuvant Phase II Trial in Patients With Non–Small-Cell Lung Cancer: IFCT-0801 TASTE. Journal of Clinical Oncology. 32(12). 1256–1261. 42 indexed citations

9.

Renault, Aldo, et al.. (1993). Cardiomyopathies dilatées en insuffisance cardiaque sévère chez des éthyliques chroniques: évolution clinique après sevrage complet. La Revue de Médecine Interne. 14(10). 942–942. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact